Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score

Background: Clinical-pathological factors and 21-gene recurrence score (RS) influence adjuvant chemotherapy (ACT) decision for early breast cancer patients. We investigated the decision-making of ACT in patients with discordant risk classifications of clinical-pathological factors and RS. Methods: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Weiqi, Lin, Lin, Fei, Xiaochun, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066016/
https://www.ncbi.nlm.nih.gov/pubmed/32201521
http://dx.doi.org/10.7150/jca.38976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066016/
https://www.ncbi.nlm.nih.gov/pubmed/32201521
http://dx.doi.org/10.7150/jca.38976

Ejemplares similares